• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COL5A2 作为胃癌和肾转移的潜在临床生物标志物。

COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis.

机构信息

Emergency Department, Weifang People's Hospital.

Anaesthesiology Department, Weifang Maternal and Child Health Care Hospital, Weifang, Shandong Province, China.

出版信息

Medicine (Baltimore). 2021 Feb 19;100(7):e24561. doi: 10.1097/MD.0000000000024561.

DOI:10.1097/MD.0000000000024561
PMID:33607786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7899835/
Abstract

BACKGROUND

Gastric cancer, characterized by insidious onset and multiple metastasis, is almost incurable and has poor prognosis, and also one of the leading causes of treatment failure and death in patients with gastric cancer (GC). However, the prognosis of collagen type V alpha2 chain (COL5A2) in GC and renal metastasis is unknown.

METHODS

Recruited 148 patients who underwent GC. The diagnosis of GC was confirmed by ultrasound imaging and pathological examination. Immunohistochemistry and RT-qPCR were performed to exam the expression level of COL5A2. The statistical methods included Pearson chi-square test, Spearman-rho correlation test, univariate and multivariate cox regression analysis. Finally, this research constructed receiver operating characteristic (ROC) curves and applied the area under the curve (AUC).

RESULTS

Based on Pearson's chi-square test, Spearman-rho test, and univariate/multivariate cox regression, pathologic grade (P < .001), renal metastasis (P < .001) and staging (P < .001) were significantly related to COL5A2. And COL5A2 expression (hazard ratio [HR]: 18.834, P < .001) is an independent risk factor of GC. The AUC was used as the degree of confidence in judging each factor: COL5A2 (AUC = 0.878, P < .001), COL1A1 (AUC = 0.636, P = .006), COL1A2 (AUC = 0.545, P = .368), and COL3A1 (AUC = 0.617, P = .019). Through the ROC result, COL5A2 had more advantage as a biomarker for GC than other collagens.

CONCLUSIONS

COL5A2 gene expression level might be a risk factor for GC. COL5A2 has a strong correlation with the prognosis of the disease.

摘要

背景

胃癌具有隐匿性发病和多发性转移的特点,几乎无法治愈,预后不良,也是导致胃癌(GC)患者治疗失败和死亡的主要原因之一。然而,COL5A2 基因在 GC 和肾转移中的表达水平及其预后意义尚不清楚。

方法

招募了 148 例接受 GC 治疗的患者。通过超声成像和病理检查确诊为 GC。采用免疫组化和 RT-qPCR 检测 COL5A2 的表达水平。统计方法包括 Pearson 卡方检验、Spearman-rho 相关检验、单因素和多因素 Cox 回归分析。最后,构建了受试者工作特征(ROC)曲线并应用曲线下面积(AUC)。

结果

基于 Pearson 卡方检验、Spearman-rho 检验和单因素/多因素 Cox 回归分析,病理分级(P<0.001)、肾转移(P<0.001)和分期(P<0.001)与 COL5A2 显著相关。COL5A2 表达(风险比[HR]:18.834,P<0.001)是 GC 的独立危险因素。AUC 被用作判断每个因素的置信度:COL5A2(AUC=0.878,P<0.001)、COL1A1(AUC=0.636,P=0.006)、COL1A2(AUC=0.545,P=0.368)和 COL3A1(AUC=0.617,P=0.019)。通过 ROC 结果,COL5A2 作为 GC 生物标志物的优势强于其他胶原。

结论

COL5A2 基因表达水平可能是 GC 的危险因素。COL5A2 与疾病的预后密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e04/7899835/e932605ceb8f/medi-100-e24561-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e04/7899835/e82ec3b5f1bd/medi-100-e24561-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e04/7899835/5d48930486f4/medi-100-e24561-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e04/7899835/2f58615465d6/medi-100-e24561-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e04/7899835/e932605ceb8f/medi-100-e24561-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e04/7899835/e82ec3b5f1bd/medi-100-e24561-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e04/7899835/5d48930486f4/medi-100-e24561-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e04/7899835/2f58615465d6/medi-100-e24561-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e04/7899835/e932605ceb8f/medi-100-e24561-g004.jpg

相似文献

1
COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis.COL5A2 作为胃癌和肾转移的潜在临床生物标志物。
Medicine (Baltimore). 2021 Feb 19;100(7):e24561. doi: 10.1097/MD.0000000000024561.
2
High expression of COL5A2, a member of COL5 family, indicates the poor survival and facilitates cell migration in gastric cancer.COL5A2 是 COL5 家族的一个成员,其高表达预示着胃癌患者生存不良,并促进肿瘤细胞迁移。
Biosci Rep. 2021 Apr 30;41(4). doi: 10.1042/BSR20204293.
3
Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis.基于生物信息学分析的胃癌潜在诊断和预后生物标志物的鉴定。
J Environ Pathol Toxicol Oncol. 2023;42(4):61-68. doi: 10.1615/JEnvironPatholToxicolOncol.2023047804.
4
COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing.基于转录组学和单细胞 RNA 测序,COL5A2 是胃癌的预后相关生物标志物,并与免疫浸润相关。
BMC Med Genomics. 2023 Sep 18;16(1):220. doi: 10.1186/s12920-023-01659-9.
5
H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.H19 可作为诊断生物标志物,H19 表达上调与胃癌患者预后不良有关。
Neoplasma. 2016;63(2):223-30. doi: 10.4149/207_150821N454.
6
Collagen 1A1 (COL1A1) and Collagen11A1(COL11A1) as diagnostic biomarkers in Breast, colorectal and gastric cancers.胶原 1A1(COL1A1)和胶原 11A1(COL11A1)作为乳腺癌、结直肠癌和胃癌的诊断生物标志物。
Gene. 2024 Jan 20;892:147867. doi: 10.1016/j.gene.2023.147867. Epub 2023 Oct 1.
7
Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.TRAF2的甲基化状态与胃癌的诊断和预后相关。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):14228-34. eCollection 2015.
8
[Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].[胃癌腹膜转移风险评估模型的建立及其预测价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Jan 25;20(1):47-52.
9
Differential clinical significance of COL5A1 and COL5A2 in tongue squamous cell carcinoma.COL5A1 和 COL5A2 在舌鳞癌中的差异临床意义。
J Oral Pathol Med. 2019 Jul;48(6):468-476. doi: 10.1111/jop.12861. Epub 2019 Apr 29.
10
NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.NOB1基因作为胃癌患者临床结局和预后的潜在生物标志物
Clin Lab. 2018 Sep 1;64(9):1469-1475. doi: 10.7754/Clin.Lab.2018.180330.

引用本文的文献

1
Mimicking Gastric Cancer Collagen Reorganization with Decellularized ECM-Based Scaffolds.利用基于脱细胞细胞外基质的支架模拟胃癌的胶原重组
Biology (Basel). 2025 Aug 16;14(8):1067. doi: 10.3390/biology14081067.
2
COL5A2-mediated endoplasmic reticulum stress promotes macrophage M2 polarization in lung adenocarcinoma.COL5A2介导的内质网应激促进肺腺癌中巨噬细胞的M2极化。
Cell Stress Chaperones. 2025 May 7;30(4):100081. doi: 10.1016/j.cstres.2025.100081.
3
Knockdown TNF family prognosis index crucial gene PDE4B promoted PANoptosis of ovarian carcinoma cell:Based in vitro and in vivo experiments.
敲低肿瘤坏死因子家族预后指数关键基因PDE4B可促进卵巢癌细胞的全程序性死亡:基于体内外实验
Transl Oncol. 2025 Jun;56:102333. doi: 10.1016/j.tranon.2025.102333. Epub 2025 Apr 16.
4
MEOX2 mediates cisplatin resistance in ovarian cancer via E2F target and DNA repair pathways.MEOX2通过E2F靶点和DNA修复途径介导卵巢癌的顺铂耐药性。
J Ovarian Res. 2025 Mar 21;18(1):58. doi: 10.1186/s13048-025-01641-2.
5
Construction and verification of a prognostic model for bladder cancer based on disulfidptosis-related angiogenesis genes.基于二硫键连接的细胞焦亡相关血管生成基因构建及验证膀胱癌预后模型
PeerJ. 2025 Feb 21;13:e18911. doi: 10.7717/peerj.18911. eCollection 2025.
6
EMT-related gene classifications predict the prognosis, immune infiltration, and therapeutic response of osteosarcoma.上皮-间质转化相关基因分类可预测骨肉瘤的预后、免疫浸润及治疗反应。
Front Pharmacol. 2024 Aug 7;15:1419040. doi: 10.3389/fphar.2024.1419040. eCollection 2024.
7
COL5A2 drives regorafenib resistance-induced metastatic phenotype via reducing LIFR expression in hepatocellular carcinoma.COL5A2通过降低肝细胞癌中LIFR的表达来驱动瑞戈非尼耐药诱导的转移表型。
Acta Biochim Biophys Sin (Shanghai). 2024 May 30;56(7):997-1010. doi: 10.3724/abbs.2024058.
8
LUM as a novel prognostic marker and its correlation with immune infiltration in gastric cancer: a study based on immunohistochemical analysis and bioinformatics.LUM 作为一种新型的预后标志物及其与胃癌免疫浸润的相关性:基于免疫组织化学分析和生物信息学的研究。
BMC Gastroenterol. 2023 Dec 21;23(1):455. doi: 10.1186/s12876-023-03075-w.
9
Clinical significance and immune landscape of angiogenesis-related genes in bladder cancer.膀胱癌中血管生成相关基因的临床意义和免疫图谱。
Aging (Albany NY). 2023 Nov 20;15(22):13118-13133. doi: 10.18632/aging.205222.
10
Molecular insight into renal cancer and latest therapeutic approaches to tackle it: an updated review.肾癌的分子洞察及最新治疗方法:一篇更新综述
Med Oncol. 2023 Nov 13;40(12):355. doi: 10.1007/s12032-023-02225-0.